glp-1 for diabetic GLP-1RAs Reduce External Eating Behavior with Type 2 diabetes GLP-1 receptor agonists are increasingly
Description
23 When compared with liraglutide, the same agent reduced A1c by an equivalent amount but led to a significantly greater reduction in weight by NNC 00902746 was significantly greater than that of liraglutide (a 1.17% decrease compared to placebo)
If digestion slows too much, gastroparesis (also known as delayed gastric emptying) and gastroenteritis (among other side effects, some life-threatening like ileus which is similar to gastroparesis but happens in the intestines,) can occur

Rotate injection sites within the same region in order to reduce the risk of cutaneous amyloidosis [see Adverse Reactions (6.2)]

doi: 10.2337/dc22-1148 [DOI] [PubMed] [Google Scholar] 13.Hernn MA, Robins JM

Suitable sites include: Keep a log of injection spots to ensure proper rotation

The protein target drops to 1.2 to 1.6 g/kg (rather than the 1.6 to 1.8 g/kg recommended for GLP-1 users), and the guidance on using your medication for portion control doesnt appear
